glp-1 obesity drug news today 2025 A nice article in The Hindu today highlights the CMS Extends Medicare's Short-Term Bridge

There may be a deductible for Part D plans, but in 2026, it cannot exceed $615

And to this day, we still actually follow the algorithm: If there was a history of pancreatitis, do not use. The concern stemmed from early case reports suggesting that patients developed pancreatitis while taking GLP-1 agonists

You may notice an increase in appetite and a return of food cravings, allowing you to eat more without feeling as full

GLP-1s are at the forefront of this change, and our work with Novo Nordisk serves as a blueprint for how pharma and digital health platforms can reimagine drug access models for the future, Iyer said

Amjad S, Nisar S, Bhat AA, Shah AR, Frenneaux MP, Fakhro K, et al